Literature DB >> 15043711

Infection of stationary human brain aggregates with HIV-1 SF162 and IIIB results in transient neuronal damage and neurotoxicity.

G Trillo-Pazos1, A Kandanearatchi, J Eyeson, D King, A Vyakarnam, I P Everall.   

Abstract

The cellular basis of HIV associated dementia has been correlated with microglial activation and neuronal dysfunction in symptomatic HIV-1 disease. As a cellular model of HIV-1 infection of brain tissue in vitro, we established a stationary human brain aggregate (SHBA) system to compare infection of HIV-1 SF162 (R5 virus) to that of IIIB (X4 virus). Aggregates were analysed by immunohistochemistry, morphometry, flow cytometry and p24 ELISA. SHBAs had a 1 mm(3) size with a mixed cellular composition of 36% neurones, 27% astrocytes, 2% macrophages/microglia and 14% oligodendrocytes. Infection of SHBA's with the R5 HIV-1 SF162 virus led to the expression of HIV-1 p24 antigen in 6% of cells. Infection with this R5 using virus culminated in transient neuronal damage and a decrease in mitotically active progenitor cells within aggregates. Infection with X4 using HIV-1 IIIB was associated with astrocytosis and neurotoxicity. We propose that: (1) the pattern of cellular damage elicited by HIV-1 infection of brain tissue in vitro depends on virus subtype as determined by its preferential use of R5 or X4 chemokine receptors for entry into cells; (2) SHBAs are a reliable and readily established model of the cellular complexity of human brain tissue in vitro.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15043711     DOI: 10.1046/j.0305-1846.2003.00519.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  7 in total

1.  Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.

Authors:  Lucette A Cysique; Bruce J Brew
Journal:  J Neurovirol       Date:  2011-03-17       Impact factor: 2.643

2.  Allele specific analysis of the ADRBK2 gene in lymphoblastoid cells from bipolar disorder patients.

Authors:  Michael J McCarthy; Thomas B Barrett; Stephanie Nissen; John R Kelsoe; Eric E Turner
Journal:  J Psychiatr Res       Date:  2009-09-18       Impact factor: 4.791

3.  Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration.

Authors:  Shahid Salaria; Haleh Badkoobehi; Edward Rockenstein; Leslie Crews; Gursharan Chana; Eliezer Masliah; Ian P Everall
Journal:  J Neurovirol       Date:  2007-12       Impact factor: 2.643

4.  Upregulation of NRG-1 and VAMP-1 in human brain aggregates exposed to clozapine.

Authors:  Gursharan Chana; Ginger Lucero; Shahid Salaria; Jean Lozach; Pinyi Du; Christopher Woelk; Ian Everall
Journal:  Schizophr Res       Date:  2009-06-07       Impact factor: 4.939

5.  Glycogen synthase kinase-3beta (GSK-3beta) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus-mediated neurotoxicity in primary human neurons.

Authors:  Timothy B Nguyen; Ginger R Lucero; Gursharan Chana; Britta J Hult; Erick T Tatro; Eliezer Masliah; Igor Grant; Cristian L Achim; Ian P Everall
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

6.  Successful application of hyperbranched multidisplacement genomic amplification to detect HIV-1 sequences in single neurons removed from autopsy brain sections by laser capture microdissection.

Authors:  Jorge E Torres-Muñoz; Mariana Núñez; Carol K Petito
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

7.  Structural brain alterations can be detected early in HIV infection.

Authors:  Ann B Ragin; Hongyan Du; Renee Ochs; Ying Wu; Christina L Sammet; Alfred Shoukry; Leon G Epstein
Journal:  Neurology       Date:  2012-11-28       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.